PRMT2 Products
(Protein Arginine Methyltransferase 2 (PRMT2))
Categories
Arginine methyltransferase that methylates the guanidino nitrogens of arginyl residues in proteins such as histones. Involved in growth regulation (By similarity). Involved in embryonic dorsal development.
antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.
Featured PRMT2 Categories
PRMT2 Antibodies
High quality antibodies with extensive validation data.
PRMT2 Proteins
Proteins for various applications incl. WB, ELISA, IF etc.
Recommended PRMT2 Antibodies
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Cow, Dog, Guinea Pig, Horse, Human, Mouse, Pig, Rabbit, Rat
Application
WB, IHC
Validations
- (4)
- (5)
Cat. No.
ABIN2778663
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, IHC, IF
Validations
- (4)
Cat. No.
ABIN6146227
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, IHC, ELISA
Validations
- (5)
Cat. No.
ABIN3032356
Quantity
0.4 mL
Datasheet
Datasheet
Recommended PRMT2 Proteins
Product
Reactivity
Source
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Source
Wheat germ
Validations
- (1)
Cat. No.
ABIN1316329
Quantity
10 μg
Datasheet
Datasheet
Reactivity
Mouse
Source
Tobacco (Nicotiana tabacum)
Validations
Cat. No.
ABIN3137442
Quantity
1 mg
Datasheet
Datasheet
Reactivity
Human
Source
Tobacco (Nicotiana tabacum)
Validations
Cat. No.
ABIN3089171
Quantity
1 mg
Datasheet
Datasheet
Latest Publications for our PRMT2 products
: "Effects of oxygen on the antigenic landscape of prostate cancer cells." in: BMC research notes, Vol. 8, pp. 687, (2016) (PubMed).: "Nuclear loss of protein arginine N-methyltransferase 2 in breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein." in: Oncogene, Vol. 33, Issue 48, pp. 5546-58, (2014) (PubMed).
: "Single-cell profiling of epigenetic modifiers identifies PRDM14 as an inducer of cell fate in the mammalian embryo." in: Cell reports, Vol. 5, Issue 3, pp. 687-701, (2013) (PubMed).
: "Identification and characterization of novel spliced variants of PRMT2 in breast carcinoma." in: The FEBS journal, Vol. 279, Issue 2, pp. 316-35, (2012) (PubMed).
: "Expression of trisomic proteins in Down syndrome model systems." in: Gene, Vol. 512, Issue 2, pp. 219-25, (2012) (PubMed).
: "Identification and expression analysis of a novel transcript of the human PRMT2 gene resulted from alternative polyadenylation in breast cancer." in: Gene, Vol. 487, Issue 1, pp. 1-9, (2011) (PubMed).
: "PRMT2, a member of the protein arginine methyltransferase family, is a coactivator of the androgen receptor." in: The Journal of steroid biochemistry and molecular biology, Vol. 107, Issue 1-2, pp. 1-14, (2007) (PubMed).
: "Protein methyltransferase 2 inhibits NF-kappaB function and promotes apoptosis." in: Molecular and cellular biology, Vol. 26, Issue 10, pp. 3864-74, (2006) (PubMed).
: "Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha." in: The Journal of biological chemistry, Vol. 277, Issue 32, pp. 28624-30, (2002) (PubMed).
Synonyms and alternative names related to PRMT2
protein arginine methyltransferase 2 (PRMT2), protein arginine methyltransferase 2 (Prmt2), protein arginine methyltransferase 2 L homeolog (prmt2.L), protein arginine N-methyltransferase 2 (Prmt2), AI504737, DKFZp459N1919, HRMT1L1, Hrmt1l1, PRMT2Protein level used designations for PRMT2
- protein arginine methyltransferase 2
- protein arginine N-methyltransferase 2-like
- HMT1 (hnRNP methyltransferase, S. cerevisiae)-like 1
- HMT1 hnRNP methyltransferase-like 1
- PRMT2 alpha
- PRMT2 beta
- PRMT2 gamma
- histone-arginine N-methyltransferase PRMT2
- protein arginine N-methyltransferase 2
- Histone-arginine N-methyltransferase PRMT2
- heterogeneous nuclear ribonucleoprotein methyltransferase-like 1
You are here:
